Biomarker-stratified Therapy for Patients with non-small cell Lung Cancer When should the Tests be done?

被引：0
|
作者：
Griesinger, Frank [1 ,2 ]
Thomas, Michael [3 ,4 ]
机构：
[1] Univ Klin Innere Med Onkol, Pius Hosp Olden Burg, Oldenburg, Germany
[2] Canc Ctr Oldenburg, Oldenburg, Germany
[3] Univ Klinikum Heidelberg, Abt Internist Onkol Thorakaler Tumoren, Thoraxklin, Heidelberg, Germany
[4] NCT Heidelberg, Heidelberg, Germany
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2021年 / 146卷 / 08期
关键词：
D O I：
10.1055/a-1383-5231
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：559 / 561
页数：3
相关论文
共 50 条
  • [1] When to Test in Biomarker-stratified Therapy of Non-small Cell Lung Cancer Biomarker-stratified Therapy of Non-small Cell Lung Cancer: When and What to Test?
    Griesinger, Frank
    Thomas, Michael
    [J]. PNEUMOLOGIE, 2021, 75 (09): : 641 - 643
  • [2] What, When, and How of Biomarker Testing in Non-Small Cell Lung Cancer
    Riely, Gregory L.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (5.5): : 686 - 688
  • [3] Predictive biomarker analysis of non-small cell lung cancer patients
    Sakellariou, S.
    Karatrasoglou, E. A.
    Chatziandreou, I.
    Giannopoulou, I.
    Michelli, M.
    Zougros, A.
    Rouppou, E.
    Stamopoulos, K.
    Lazaris, A. C.
    Korkolopoulou, P.
    Saetta, A.
    [J]. VIRCHOWS ARCHIV, 2019, 475 : S105 - S105
  • [4] MicroRNAs: A novel potential biomarker for diagnosis and therapy in patients with non-small cell lung cancer
    Zhou, Qun
    Huang, Shao-Xin
    Zhang, Feng
    Li, Shu-Jun
    Liu, Cong
    Xi, Yong-Yong
    Wang, Liang
    Wang, Xin
    He, Qi-Qiang
    Sun, Cheng-Cao
    Li, De-Jia
    [J]. CELL PROLIFERATION, 2017, 50 (06)
  • [5] Access to Biomarker Testing in Patients with Advanced Non-Small Cell Lung Cancer
    Ganti, Apar
    Hirsch, Fred R.
    Wynes, Murry
    Ravelo, Arliene
    Ramalingam, Suresh
    Ionescu-Ittu, Raluca
    Pivneva, Irina
    Borghaei, Hossein
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S964 - S965
  • [6] Collagen XXIII: A biomarker for non-small cell lung cancer
    Spivey, Kristin A.
    Banyard, Jacqueline
    Solis, Luisa M.
    Wistuba, Ignacio I.
    Barletta, Justine A.
    Gandhi, Leena
    Feldman, Henry A.
    Rodig, Scott J.
    Chirieac, Lucian R.
    Zetter, Bruce R.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [7] BIOMARKER FOR BRAIN METASTASIS OF NON-SMALL CELL LUNG CANCER
    Yang, Seung-Ho
    Yoo, Jin Young
    Cho, Deog Gon
    Kim, Hoo Kyo
    Kim, Sung Whan
    Lee, Sang Won
    [J]. NEURO-ONCOLOGY, 2010, 12 : 64 - 64
  • [8] Osteopontin is a prognostic biomarker in non-small cell lung cancer
    Rud, Ane Kongsgaard
    Boye, Kjetil
    Oijordsbakken, Miriam
    Lund-Iversen, Marius
    Halvorsen, Ann Rita
    Solberg, Steinar K.
    Berge, Gisle
    Helland, Aslaug
    Brustugun, Odd Terje
    Maelandsmo, Gunhild M.
    [J]. BMC CANCER, 2013, 13
  • [9] Targeted Therapy for Patients With Metastatic Non-Small Cell Lung Cancer
    Reckamp, Karen L.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (05): : 601 - 604
  • [10] Salvage therapy in patients with advanced non-small cell lung cancer
    Bedano, Pablo M.
    Hanna, Nasser H.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (06) : 582 - 587
12345